KTMC Achieves $239 Million Recovery for Investors in Celgene Securities Fraud Case Authors of this newsletter: Matthew Mustokoff , Aubrie Kent Following seven years of vigorous litigation, Kessler Topaz recently secured a landmark $239 million settlement in In re Celgene Corp. Securities […] Read More
KTMC Attains $78 Million Recovery for Investors in Catalent Quality Control and Accounting Fraud Case Authors of this newsletter: Joshua D'Ancona , Ryan Shelton-Benson After nearly three years of litigation in New Jersey federal court, on December 22, 2025, the parties in City of Warwick […] Read More
SEC Chairman Signals Intent to Curtail Shareholder Litigation Authors of this newsletter: Karissa Sauder During his ten months as Chairman of the United States Securities and Exchange Commission (the “SEC”), Paul Atkins has indicated […] Read More
Kessler Topaz Finalizing $70 Million Settlement After Check-Up of Veterinary Company Merger Authors of this newsletter: Michael McCutcheon Kessler Topaz is in the process of finalizing a $70 million cash settlement concerning a lawsuit brought by former stockholders […] Read More
Court Denies Social Media Companies’ Request for Summary Judgment; School District Trials Will Begin This Summer Authors of this newsletter: Daniel Dicce On February 9, 2026, Judge Gonzalez Rogers of the Northern District of California denied Meta, Snap, TikTok, and YouTube’s (“Defendants”) […] Read More
KTMC Files Novel Antitrust Action Based on Improper Patent Listing Authors of this newsletter: Matthew Macken KTMC recently filed a novel antitrust action alleging that Novartis Pharmaceuticals Corporation (“Novartis”) illegally extended its monopoly for the blockbuster […] Read More
